BioPharma
AstraZeneca plans to invest $50 billion in America for...
AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is...
Clinical Trials
UK government, Manufacturing, Investment, Clinical trials
The UK government will improve manufacturing and commercialisation as it seeks to maximise the value of the life sciences sector growth for the country's economy.
In...
Clinical Trials
AI in Alzheimer Drug Development to Enhances Clinical Trials
Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to medical...
Clinical Trials
Merck to Initiate Phase 3 Trials for Investigational Once-Monthly...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of the EXPrESSIVE Phase 3 clinical trials, evaluating...
Drug Research
China Unveils Innovative Drugs Policy to Boost Development
The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support...
Drug Research
Hikma Pharmaceuticals USA announces $1 Billion of new US...
London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it...
BioPharma
Biopharma Production with AI: A New Era in Manufacturing
A New Era of Biopharma Production with AI
The biopharma industry is undergoing a transformation as it capitalises on the potential of artificial intelligence (AI) to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.